Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 106 entries
Sorted by: Best Match Show Resources per page
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Annals of intensive care

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M.
PMID: 27638133
Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15.

Neutropenia is defined by either an absolute or functional defect (acute myeloid leukemia or myelodysplastic syndrome) of polymorphonuclear neutrophils and is associated with high risk of specific complications that may require intensive care unit (ICU) admission. Specificities in the...

Cite
Schnell D, Azoulay E, Benoit D, et al. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care. 2016;6(1):90doi: 10.1186/s13613-016-0189-6.
Schnell, D., Azoulay, E., Benoit, D., Clouzeau, B., Demaret, P., Ducassou, S., Frange, P., Lafaurie, M., Legrand, M., Meert, A. P., Mokart, D., Naudin, J., Pene, F., Rabbat, A., Raffoux, E., Ribaud, P., Richard, J. C., Vincent, F., Zahar, J. R., & Darmon, M. (2016). Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Annals of intensive care, 6(1), 90. https://doi.org/10.1186/s13613-016-0189-6
Schnell, David, et al. "Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)." Annals of intensive care vol. 6,1 (2016): 90. doi: https://doi.org/10.1186/s13613-016-0189-6
Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15. PMID: 27638133; PMCID: PMC5025409.
Copy Download .nbib Format: NLM
Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen.

Journal of surgical case reports

di Summa PG, Yvon A, Larcher L, Raffoul W, Koch N.
PMID: 25672974
J Surg Case Rep. 2015 Feb 10;2015(2). doi: 10.1093/jscr/rjv002.

Propionibacterium avidum is a common inhabitant of sebaceous glands, traditionally considered to be of low virulence and generally found on implanted foreign material. We report a rare case of P. avidum breast abscess, causing severe morbidity following breast reduction...

Cite
di Summa PG, Yvon A, Larcher L, et al. Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen. J Surg Case Rep. 2015;2015(2)doi: 10.1093/jscr/rjv002.
di Summa, P. G., Yvon, A., Larcher, L., Raffoul, W., & Koch, N. (2015). Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen. Journal of surgical case reports, 2015(2), . https://doi.org/10.1093/jscr/rjv002
di Summa, Pietro G, et al. "Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen." Journal of surgical case reports vol. 2015,2 (2015). doi: https://doi.org/10.1093/jscr/rjv002
di Summa PG, Yvon A, Larcher L, Raffoul W, Koch N. Propionibacterium avidum infection following breast reduction: high morbidity from a low-virulence pathogen. J Surg Case Rep. 2015 Feb 10;2015(2). doi: 10.1093/jscr/rjv002. PMID: 25672974; PMCID: PMC4323737.
Copy Download .nbib Format: NLM
Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration?.

Neural regeneration research

de Luca AC, Lacour SP, Raffoul W, di Summa PG.
PMID: 25598773
Neural Regen Res. 2014 Nov 15;9(22):1943-8. doi: 10.4103/1673-5374.145366.

Peripheral nerve injury is a serious problem affecting significantly patients' life. Autografts are the "gold standard" used to repair the injury gap, however, only 50% of patients fully recover from the trauma. Artificial conduits are a valid alternative to...

Cite
de Luca AC, Lacour SP, Raffoul W, et al. Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration?. Neural Regen Res. 2014;9(22):1943-8doi: 10.4103/1673-5374.145366.
de Luca, A. C., Lacour, S. P., Raffoul, W., & di Summa, P. G. (2014). Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration?. Neural regeneration research, 9(22), 1943-8. https://doi.org/10.4103/1673-5374.145366
de Luca, Alba C, et al. "Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration?." Neural regeneration research vol. 9,22 (2014): 1943-8. doi: https://doi.org/10.4103/1673-5374.145366
de Luca AC, Lacour SP, Raffoul W, di Summa PG. Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration?. Neural Regen Res. 2014 Nov 15;9(22):1943-8. doi: 10.4103/1673-5374.145366. PMID: 25598773; PMCID: PMC4283273.
Copy Download .nbib Format: NLM
Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane oxygenation support.

European heart journal. Acute cardiovascular care

Roussel A, Al-Attar N, Alkhoder S, Radu C, Raffoul R, Alshammari M, Montravers P, Wolff M, Nataf P.
PMID: 24062897
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):111-4. doi: 10.1177/2048872612449417.

INTRODUCTION: We report and examine the outcomes of emergency venoarterial extracorporeal membrane oxygenation (ECMO) support initiated via percutaneous cannulation of the femoral vessels.PATIENTS AND METHODS: Fifteen patients undergoing percutaneous venoarterial ECMO under emergency circumstances between January 2009 and July...

Cite
Roussel A, Al-Attar N, Alkhoder S, et al. Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane oxygenation support. Eur Heart J Acute Cardiovasc Care. 2012;1(2):111-4doi: 10.1177/2048872612449417.
Roussel, A., Al-Attar, N., Alkhoder, S., Radu, C., Raffoul, R., Alshammari, M., Montravers, P., Wolff, M., & Nataf, P. (2012). Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane oxygenation support. European heart journal. Acute cardiovascular care, 1(2), 111-4. https://doi.org/10.1177/2048872612449417
Roussel, Arnaud, et al. "Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane oxygenation support." European heart journal. Acute cardiovascular care vol. 1,2 (2012): 111-4. doi: https://doi.org/10.1177/2048872612449417
Roussel A, Al-Attar N, Alkhoder S, Radu C, Raffoul R, Alshammari M, Montravers P, Wolff M, Nataf P. Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane oxygenation support. Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):111-4. doi: 10.1177/2048872612449417. PMID: 24062897; PMCID: PMC3760531.
Copy Download .nbib Format: NLM
Topical Negative Pressure on Burns: An Innovative Method for Wound Exudate Collection.

Plastic and reconstructive surgery. Global open

Baudoin J, Jafari P, Meuli J, Applegate LA, Raffoul W.
PMID: 27975022
Plast Reconstr Surg Glob Open. 2016 Nov 10;4(11):e1117. doi: 10.1097/GOX.0000000000001117. eCollection 2016 Nov.

Burn wound exudate is an important source of information on the wound-healing process and systemic improvement of burn patients. Identification of biomarkers for the prediagnosis of local or systemic complications in patients will have a great impact on adapting...

Cite
Baudoin J, Jafari P, Meuli J, et al. Topical Negative Pressure on Burns: An Innovative Method for Wound Exudate Collection. Plast Reconstr Surg Glob Open. 2016;4(11):e1117doi: 10.1097/GOX.0000000000001117.
Baudoin, J., Jafari, P., Meuli, J., Applegate, L. A., & Raffoul, W. (2016). Topical Negative Pressure on Burns: An Innovative Method for Wound Exudate Collection. Plastic and reconstructive surgery. Global open, 4(11), e1117. https://doi.org/10.1097/GOX.0000000000001117
Baudoin, Julien, et al. "Topical Negative Pressure on Burns: An Innovative Method for Wound Exudate Collection." Plastic and reconstructive surgery. Global open vol. 4,11 (2016): e1117. doi: https://doi.org/10.1097/GOX.0000000000001117
Baudoin J, Jafari P, Meuli J, Applegate LA, Raffoul W. Topical Negative Pressure on Burns: An Innovative Method for Wound Exudate Collection. Plast Reconstr Surg Glob Open. 2016 Nov 10;4(11):e1117. doi: 10.1097/GOX.0000000000001117. eCollection 2016 Nov. PMID: 27975022; PMCID: PMC5142488.
Copy Download .nbib Format: NLM
Implementing Evidence-Based HIV Prevention for Female Sex Workers in Mexico: Provider Assessments of Feasibility and Acceptability.

Global social welfare : research, policy & practice

Palinkas LA, Um MY, Aarons GA, Rafful C, Chavarin CV, Mendoza DV, Staines H, Patterson TL.
PMID: 31632894
Glob Soc Welf. 2019 Jun;6(2):57-68. doi: 10.1007/s40609-018-0113-0. Epub 2018 May 09.

This study examined service provider perceptions of feasibility and acceptability of implementing evidence-based practices for preventing HIV/AIDS and STIs in female sex workers (FSWs) in Mexico. Semi-structured interviews were conducted with 124 directors, supervisors and counselors from 12 reproductive...

Cite
Palinkas LA, Um MY, Aarons GA, et al. Implementing Evidence-Based HIV Prevention for Female Sex Workers in Mexico: Provider Assessments of Feasibility and Acceptability. Glob Soc Welf. 2018;6(2):57-68doi: 10.1007/s40609-018-0113-0.
Palinkas, L. A., Um, M. Y., Aarons, G. A., Rafful, C., Chavarin, C. V., Mendoza, D. V., Staines, H., & Patterson, T. L. (2019). Implementing Evidence-Based HIV Prevention for Female Sex Workers in Mexico: Provider Assessments of Feasibility and Acceptability. Global social welfare : research, policy & practice, 6(2), 57-68. https://doi.org/10.1007/s40609-018-0113-0
Palinkas, Lawrence A, et al. "Implementing Evidence-Based HIV Prevention for Female Sex Workers in Mexico: Provider Assessments of Feasibility and Acceptability." Global social welfare : research, policy & practice vol. 6,2 (2019): 57-68. doi: https://doi.org/10.1007/s40609-018-0113-0
Palinkas LA, Um MY, Aarons GA, Rafful C, Chavarin CV, Mendoza DV, Staines H, Patterson TL. Implementing Evidence-Based HIV Prevention for Female Sex Workers in Mexico: Provider Assessments of Feasibility and Acceptability. Glob Soc Welf. 2019 Jun;6(2):57-68. doi: 10.1007/s40609-018-0113-0. Epub 2018 May 09. PMID: 31632894; PMCID: PMC6800729.
Copy Download .nbib Format: NLM
Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema.

Microvascular research

Buso G, Favre L, Maufus M, Honorati M, Lessert C, Depairon M, Raffoul W, Tomson D, Mazzolai L.
PMID: 34896377
Microvasc Res. 2021 Dec 09;140:104298. doi: 10.1016/j.mvr.2021.104298. Epub 2021 Dec 09.

OBJECTIVE: Lipedema is a chronic and progressive disease associated with lymphatic impairment at later stages. The aim of our study was to describe the functional status and anatomy of lower limb superficial lymphatic system using indocyanine green (ICG) lymphography...

Cite
Buso G, Favre L, Maufus M, et al. Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema. Microvasc Res. 2021;140:104298doi: 10.1016/j.mvr.2021.104298.
Buso, G., Favre, L., Maufus, M., Honorati, M., Lessert, C., Depairon, M., Raffoul, W., Tomson, D., & Mazzolai, L. (2021). Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema. Microvascular research, 140104298. https://doi.org/10.1016/j.mvr.2021.104298
Buso, Giacomo, et al. "Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema." Microvascular research vol. 140 (2021): 104298. doi: https://doi.org/10.1016/j.mvr.2021.104298
Buso G, Favre L, Maufus M, Honorati M, Lessert C, Depairon M, Raffoul W, Tomson D, Mazzolai L. Indocyanine green lymphography as novel tool to assess lymphatics in patients with lipedema. Microvasc Res. 2021 Dec 09;140:104298. doi: 10.1016/j.mvr.2021.104298. Epub 2021 Dec 09. PMID: 34896377.
Copy Download .nbib Format: NLM
Massive burns: retrospective analysis of changes in outcomes indicators across 18 years.

Journal of burn care & research : official publication of the American Burn Association

Meuli JN, Pantet O, Berger MM, Waselle L, Raffoul W.
PMID: 33886955
J Burn Care Res. 2021 Apr 22; doi: 10.1093/jbcr/irab072. Epub 2021 Apr 22.

BACKGROUND: The treatment and management of massive burns, defined as burns affecting≥ 50% of total body surface area (TBSA) has considerably changed since the 90s. This study aimed at analyzing if the length of intensive care unit (ICU) stay,...

Cite
Meuli JN, Pantet O, Berger MM, et al. Massive burns: retrospective analysis of changes in outcomes indicators across 18 years. J Burn Care Res. 2021;doi: 10.1093/jbcr/irab072.
Meuli, J. N., Pantet, O., Berger, M. M., Waselle, L., & Raffoul, W. (2021). Massive burns: retrospective analysis of changes in outcomes indicators across 18 years. Journal of burn care & research : official publication of the American Burn Association, . https://doi.org/10.1093/jbcr/irab072
Meuli, Joachim N, et al. "Massive burns: retrospective analysis of changes in outcomes indicators across 18 years." Journal of burn care & research : official publication of the American Burn Association vol. (2021). doi: https://doi.org/10.1093/jbcr/irab072
Meuli JN, Pantet O, Berger MM, Waselle L, Raffoul W. Massive burns: retrospective analysis of changes in outcomes indicators across 18 years. J Burn Care Res. 2021 Apr 22; doi: 10.1093/jbcr/irab072. Epub 2021 Apr 22. PMID: 33886955.
Copy Download .nbib Format: NLM
Late avulsion of a free flap in a patient with severe psychiatric illness: Establishing a successful salvage strategy.

Archives of plastic surgery

Schaffer C, Hart A, Watfa W, Raffoul W, di Summa PG.
PMID: 31006183
Arch Plast Surg. 2019 Apr 20;589-593. doi: 10.5999/aps.2018.01039. Epub 2019 Apr 20.

Post-traumatic defects of the distal third of the leg often require skipping a few steps of the well-established reconstructive ladder, due to the limited local reliable reconstructive options. In rare cases, the reconstructive plan and flap choice may encounter...

Cite
Schaffer C, Hart A, Watfa W, et al. Late avulsion of a free flap in a patient with severe psychiatric illness: Establishing a successful salvage strategy. Arch Plast Surg. 2019;589-593doi: 10.5999/aps.2018.01039.
Schaffer, C., Hart, A., Watfa, W., Raffoul, W., & di Summa, P. G. (2019). Late avulsion of a free flap in a patient with severe psychiatric illness: Establishing a successful salvage strategy. Archives of plastic surgery, 589-593. https://doi.org/10.5999/aps.2018.01039
Schaffer, Clara, et al. "Late avulsion of a free flap in a patient with severe psychiatric illness: Establishing a successful salvage strategy." Archives of plastic surgery vol. (2019): 589-593. doi: https://doi.org/10.5999/aps.2018.01039
Schaffer C, Hart A, Watfa W, Raffoul W, di Summa PG. Late avulsion of a free flap in a patient with severe psychiatric illness: Establishing a successful salvage strategy. Arch Plast Surg. 2019 Apr 20;589-593. doi: 10.5999/aps.2018.01039. Epub 2019 Apr 20. PMID: 31006183; PMCID: PMC6882698.
Copy Download .nbib Format: NLM
Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.

Leukemia

Kayser S, Rahmé R, Martínez-Cuadrón D, Ghiaur G, Thomas X, Sobas M, Guerci-Bresler A, Garrido A, Pigneux A, Gil C, Raffoux E, Tormo M, Vey N, de la Serna J, Salamero O, Lengfelder E, Levis MJ, Fenaux P, Sanz MA, Platzbecker U, Schlenk RF, Adès L, Montesinos P.
PMID: 34785795
Leukemia. 2021 Dec;35(12):3631. doi: 10.1038/s41375-021-01358-3.

No abstract available.

Cite
Kayser S, Rahmé R, Martínez-Cuadrón D, et al. Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia. 2021;35(12):3631doi: 10.1038/s41375-021-01358-3.
Kayser, S., Rahmé, R., Martínez-Cuadrón, D., Ghiaur, G., Thomas, X., Sobas, M., Guerci-Bresler, A., Garrido, A., Pigneux, A., Gil, C., Raffoux, E., Tormo, M., Vey, N., de la Serna, J., Salamero, O., Lengfelder, E., Levis, M. J., Fenaux, P., Sanz, M. A., Platzbecker, U., Schlenk, R. F., Adès, L., & Montesinos, P. (2021). Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia, 35(12), 3631. https://doi.org/10.1038/s41375-021-01358-3
Kayser, Sabine, et al. "Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study." Leukemia vol. 35,12 (2021): 3631. doi: https://doi.org/10.1038/s41375-021-01358-3
Kayser S, Rahmé R, Martínez-Cuadrón D, Ghiaur G, Thomas X, Sobas M, Guerci-Bresler A, Garrido A, Pigneux A, Gil C, Raffoux E, Tormo M, Vey N, de la Serna J, Salamero O, Lengfelder E, Levis MJ, Fenaux P, Sanz MA, Platzbecker U, Schlenk RF, Adès L, Montesinos P. Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study. Leukemia. 2021 Dec;35(12):3631. doi: 10.1038/s41375-021-01358-3. PMID: 34785795; PMCID: PMC8632664.
Copy Download .nbib Format: NLM
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy.

Blood

Itzykson R, Fournier E, Berthon C, Röllig C, Braun T, Marceau-Renaut A, Pautas C, Nibourel O, Lemasle E, Micol JB, Adès L, Lebon D, Malfuson JV, Gastaud L, Goursaud L, Raffoux E, Wattebled KJ, Rousselot P, Thomas X, Chantepie S, Cluzeau T, Serve H, Boissel N, Terré C, Celli-Lebras K, Preudhomme C, Thiede C, Dombret H, Gardin C, Duployez N.
PMID: 34410352
Blood. 2021 Aug 19;138(7):507-519. doi: 10.1182/blood.2021011103.

To design a simple and reproducible classifier predicting the overall survival (OS) of patients with acute myeloid leukemia (AML) ≥60 years of age treated with 7 + 3, we sequenced 37 genes in 471 patients from the ALFA1200 (Acute...

Cite
Itzykson R, Fournier E, Berthon C, et al. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood. 2021;138(7):507-519doi: 10.1182/blood.2021011103.
Itzykson, R., Fournier, E., Berthon, C., Röllig, C., Braun, T., Marceau-Renaut, A., Pautas, C., Nibourel, O., Lemasle, E., Micol, J. B., Adès, L., Lebon, D., Malfuson, J. V., Gastaud, L., Goursaud, L., Raffoux, E., Wattebled, K. J., Rousselot, P., Thomas, X., Chantepie, S., Cluzeau, T., Serve, H., Boissel, N., Terré, C., Celli-Lebras, K., Preudhomme, C., Thiede, C., Dombret, H., Gardin, C., & Duployez, N. (2021). Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood, 138(7), 507-519. https://doi.org/10.1182/blood.2021011103
Itzykson, Raphael, et al. "Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy." Blood vol. 138,7 (2021): 507-519. doi: https://doi.org/10.1182/blood.2021011103
Itzykson R, Fournier E, Berthon C, Röllig C, Braun T, Marceau-Renaut A, Pautas C, Nibourel O, Lemasle E, Micol JB, Adès L, Lebon D, Malfuson JV, Gastaud L, Goursaud L, Raffoux E, Wattebled KJ, Rousselot P, Thomas X, Chantepie S, Cluzeau T, Serve H, Boissel N, Terré C, Celli-Lebras K, Preudhomme C, Thiede C, Dombret H, Gardin C, Duployez N. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood. 2021 Aug 19;138(7):507-519. doi: 10.1182/blood.2021011103. PMID: 34410352.
Copy Download .nbib Format: NLM
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.

Blood

Duchmann M, Micol JB, Duployez N, Raffoux E, Thomas X, Marolleau JP, Braun T, Adès L, Chantepie S, Lemasle E, Berthon C, Malfuson JV, Pautas C, Lambert J, Boissel N, Celli-Lebras K, Caillot D, Turlure P, Vey N, Pigneux A, Recher C, Terré C, Gardin C, Itzykson R, Preudhomme C, Dombret H, de Botton S.
PMID: 33881523
Blood. 2021 May 20;137(20):2827-2837. doi: 10.1182/blood.2020010165.

In patients with isocitrate dehydrogenase (IDH)-mutated acute myeloid leukemia (AML) treated by intensive chemotherapy (IC), prognostic significance of co-occurring genetic alterations and allogeneic hematopoietic stem cell transplantation (HSCT) are of particular interest with the advent of IDH1/2 mutant inhibitors....

Cite
Duchmann M, Micol JB, Duployez N, et al. Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study. Blood. 2021;137(20):2827-2837doi: 10.1182/blood.2020010165.
Duchmann, M., Micol, J. B., Duployez, N., Raffoux, E., Thomas, X., Marolleau, J. P., Braun, T., Adès, L., Chantepie, S., Lemasle, E., Berthon, C., Malfuson, J. V., Pautas, C., Lambert, J., Boissel, N., Celli-Lebras, K., Caillot, D., Turlure, P., Vey, N., Pigneux, A., Recher, C., Terré, C., Gardin, C., Itzykson, R., Preudhomme, C., Dombret, H., & de Botton, S. (2021). Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study. Blood, 137(20), 2827-2837. https://doi.org/10.1182/blood.2020010165
Duchmann, Matthieu, et al. "Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study." Blood vol. 137,20 (2021): 2827-2837. doi: https://doi.org/10.1182/blood.2020010165
Duchmann M, Micol JB, Duployez N, Raffoux E, Thomas X, Marolleau JP, Braun T, Adès L, Chantepie S, Lemasle E, Berthon C, Malfuson JV, Pautas C, Lambert J, Boissel N, Celli-Lebras K, Caillot D, Turlure P, Vey N, Pigneux A, Recher C, Terré C, Gardin C, Itzykson R, Preudhomme C, Dombret H, de Botton S. Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study. Blood. 2021 May 20;137(20):2827-2837. doi: 10.1182/blood.2020010165. PMID: 33881523.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 106 entries